91 related articles for article (PubMed ID: 6324430)
1. [Entamoeba histolytica: II. Effect of humoral immune mechanisms on cytotoxic activity].
Hudler H; Scheiner O; Stemberger H; Kollaritsch H; Wiedermann G
Tropenmed Parasitol; 1984 Mar; 35(1):5-8. PubMed ID: 6324430
[TBL] [Abstract][Full Text] [Related]
2. Interaction of serum components with the cytotoxic action of Entamoeba histolytica.
Wiedermann G; Scheiner O; Kollaritsch H; Hudler H; Stemberger H
Acta Trop; 1986 Sep; 43(3):245-54. PubMed ID: 2877551
[TBL] [Abstract][Full Text] [Related]
3. Interaction of different strains of Entamoeba histolytica with target cells: characterization of electrophysiological and morphological features.
Kollaritsch H; Graf J; Stemberger H; Krumpolz B; Binder M; Scheiner O; Wiedermann G
Immunobiology; 1989 Jun; 179(2-3):190-201. PubMed ID: 2551817
[TBL] [Abstract][Full Text] [Related]
4. [Entamoeba histolytica: I. Mechanism of cytotoxic activity].
Hudler H; Stemberger H; Scheiner O; Kollaritsch H; Wiedermann G
Tropenmed Parasitol; 1983 Dec; 34(4):248-52. PubMed ID: 6320511
[TBL] [Abstract][Full Text] [Related]
5. Enhanced pro-inflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica : basis of invasive disease.
Sharma M; Vohra H; Bhasin D
Parasitology; 2005 Dec; 131(Pt 6):783-96. PubMed ID: 16336732
[TBL] [Abstract][Full Text] [Related]
6. Experimental amebiasis. IV. Amebal viruses and the virulence of Entamoeba histolytica.
Mattern CF; Keister DB; Diamond LS
Am J Trop Med Hyg; 1979 Jul; 28(4):653-7. PubMed ID: 223459
[TBL] [Abstract][Full Text] [Related]
7. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica.
Reed SL; Curd JG; Gigli I; Gillin FD; Braude AI
J Immunol; 1986 Mar; 136(6):2265-70. PubMed ID: 2869084
[TBL] [Abstract][Full Text] [Related]
8. Experimental amebiasis. III. A rapid in vitro assay for virulence of Entamoeba histolytica.
Mattern CF; Keister DB; Caspar PA
Am J Trop Med Hyg; 1978 Sep; 27(5):882-7. PubMed ID: 213981
[TBL] [Abstract][Full Text] [Related]
9. Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage.
Salata RA; Pearson RD; Ravdin JI
J Clin Invest; 1985 Aug; 76(2):491-9. PubMed ID: 2863284
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate: ferredoxin oxidoreductase from Entamoeba histolytica recognized by a monoclonal antibody.
Thammapalerd N; Kotimanusvanij D; Duchêne M; Upcroft JA; Mitchell R; Healey A; Samarawickrema N; Tharavanij S; Wiedermann G; Upcroft P
Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):63-70. PubMed ID: 9031403
[TBL] [Abstract][Full Text] [Related]
11. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.
Campos-Rodríguezp R; Jarillo-Luna A
Parasite Immunol; 2005; 27(1-2):1-8. PubMed ID: 15813717
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Entamoeba histolytica proteolytic activity by human salivary IgA antibodies.
Guerrero-Manríquez GG; Sánchez-Ibarra F; Avila EE
APMIS; 1998 Nov; 106(11):1088-94. PubMed ID: 9890272
[TBL] [Abstract][Full Text] [Related]
13. [Activity of the alternative complement pathway by various axenic strains of Entamoeba histolytica].
Capin NR; Capin R; Zamacona G; Ortiz-Ortiz L
Arch Invest Med (Mex); 1978; 9 Suppl 1():291-6. PubMed ID: 211963
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional and secretory responses of Entamoeba histolytica to mucins, epithelial cells and bacteria.
Debnath A; Tashker JS; Sajid M; McKerrow JH
Int J Parasitol; 2007 Jul; 37(8-9):897-906. PubMed ID: 17362964
[TBL] [Abstract][Full Text] [Related]
15. Further studies on a cytotoxin/enterotoxin from Entamoeba histolytica.
Lushbaugh WB; Kairalla AB; Hofbauer AF; Cantey JR; Pittman FE
Arch Invest Med (Mex); 1980; 11(1 Suppl):129-33. PubMed ID: 6258506
[TBL] [Abstract][Full Text] [Related]
16. Entamoeba histolytica: surface proteolytic activity and its relationship with in vitro virulence.
Araiza-Orozco LM; Avila EE; Muñoz ML; Arias-Negrete S
Folia Parasitol (Praha); 1999; 46(3):161-7. PubMed ID: 10553649
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
18. Entamoeba histolytica: an explanation for the reported conversion of "nonpathogenic" amebae to the "pathogenic" form.
Clark CG; Diamond LS
Exp Parasitol; 1993 Dec; 77(4):456-60. PubMed ID: 8253159
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional upregulation of genes related to virulence activation in Entamoeba histolytica.
Balderas-Renteria I; García-Lázaro JF; Carranza-Rosales P; Morales-Ramos LH; Galan-Wong LJ; Muñoz-Espinosa LE
Arch Med Res; 2007 May; 38(4):372-9. PubMed ID: 17416282
[TBL] [Abstract][Full Text] [Related]
20. Serum proteins in the plasma membrane of Entamoeba histolytica.
Noya González O; Warren LG; Gohd R
Arch Invest Med (Mex); 1980; 11(1 Suppl):109-14. PubMed ID: 6258504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
